首页> 外文会议>International Meeting on Molecular Staging on Cancer >Evaluation of the Levels of bFGF, VEGF, si CAM-1, and sVCAM-1 in Serum of Patients with Thyroid Cancer
【24h】

Evaluation of the Levels of bFGF, VEGF, si CAM-1, and sVCAM-1 in Serum of Patients with Thyroid Cancer

机译:评估甲状腺癌患者血清中BFGF,VEGF,SI CAM-1和SVCAM-1水平的评估

获取原文

摘要

Tumour growth and development depend on a complex cascade of angiogenic factors. The aim of the study is evaluation of the level of growth factors VEGF and bFGF, and adhesion molecules sICAM-1, sVCAM-1 in the serum of patients with papillary thyroid cancer. The study comprised 35 patients aged 21-68 years (mean age 46+-14) who had papillary thyroid cancer diagnosed on the basis of thin needle aspiration biopsy, and were qualified for operative treatment. This group comprised 28 women and seven men. The control group was 26 healthy individuals. Serum concentrations of bFGF, VEGF, sl-CAM-1, and sVCAM-1 were evaluated by the enzyme-linked immunosorbent assay (ELISA) method. We have observed significantly higher mean concentrations of bFGF, VEGF, and sICAM-1 in the serum of patients with thyroid cancer compared with the control group. There was no significant difference between the sVCAM-1 concentrations of the thyroid cancer group and the control group.
机译:肿瘤生长和发展取决于复杂的血管生成因子级联。该研究的目的是评估VEGF和BFGF的生长因子水平,以及乳头甲状腺癌患者血清中的粘附分子SICAM-1,SAVCAM-1。该研究包括35例21-68岁的患者(平均46 + -14),患有薄薄的甲状腺癌诊断为薄针吸入活检,并且有资格进行手术治疗。该集团由28名女性和七名男子组成。对照组是26个健康的个体。通过酶联免疫吸附测定(ELISA)方法评估BFGF,VEGF,SL-CAM-1和SVCAM-1的血清浓度。与对照组相比,我们观察到甲状腺癌患者血清中的平均浓度明显高的BFGF,VEGF和SICAM-1。甲状腺癌组和对照组的SVCAM-1浓度之间没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号